4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001415889-25-007889
PRESIDENT AND CEO gave up 12,656 shares (to pay taxes)
- PRESIDENT AND CEO acquired 45,175 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jiang Wenbin PRESIDENT AND CEO | 2025-03-10 | Option exercise | +15,708 | 5,208,100 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-03-10 | Shares withheld for taxes | −4,658 | $4.36 | $20,309 | 5,203,442 | D |
| Jiang Wenbin PRESIDENT AND CEO | 2025-03-10 | Option exercise | +29,467 | 5,232,909 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-03-10 | Shares withheld for taxes | −7,998 | $4.36 | $34,871 | 5,224,911 | D |
| Derivatives | |||||||
| Jiang Wenbin PRESIDENT AND CEO | 2025-03-10 | Option exercise · Restricted Stock Units | −15,708 | 94,253 | D | ||
| Jiang Wenbin PRESIDENT AND CEO | 2025-03-10 | Option exercise · Restricted Stock Units | −29,467 | 265,206 | D | ||
Loading xslF345X05/form4-03122025_090352.xml…